SUMMARY The effects of steroidal and non-steroidal anti-inflammatory drugs on the established lesion of type II collagen induced arthritis in rats were evaluated by measuring the hind paw oedema and anti-type II collagen antibody titre. Dexamethasone, a steroidal anti-inflammatory drug, reduced the anti-type II collagen antibody titre and markedly suppressed the established lesion of type II collagen induced arthritis in rats. A rebound of the arthritis, i.e., a rapid recovery of the hind paw swelling took place after withdrawal of the treatment with steroidal antiinflammatory drugs, including dexamethasone, prednisolone, and hydrocortisone. On the other hand, indomethacin, benoxaprofen, piroxicam, and tiflamizole, which are cyclo-oxygenase inhibitors in prostaglandin synthesis, had no effect on anti-type II collagen antibody titre, but suppressed the established lesion of the arthritis without causing an apparent rebound of the arthritis after withdrawal of the drug treatment. These results suggest that the level of anti-type II collagen antibodies has no relation to the intensity of hind paw swelling in the established lesion of the arthritis, though the antibodies contribute to the incidence of the arthritis. It also indicates that non-steroidal anti-inflammatory drugs having inhibitory action on cyclo-oxygenase are useful antiarthritic drugs without causing the rebound phenomenon, an untoward side effect after withdrawal of steroidal anti-inflammatory drugs.
series were found to be stimulators of bone resorption in vitro,2 suggesting that they contribute to the destruction of joints in rheumatoid arthritis. Type II collagen induced arthritis in rats is an experimental animal model of rheumatoid arthritis. 5 In this model it is speculated that anti-type II collagen antibodies contribute to the incidence of arthritis, and prostaglandins as chemical mediators are associated with acute vascular permeability and bone resorption in the inflammatory processes of joints.
Kalindiphadke et al reported that steroidal and Accepted for publication 10 March 1987. Correspondence non-steroidal anti-inflammatory drugs were effective for treatment of type II collagen induced arthritis in rats. 4 There are scarcely any reports, however, that investigate not only anti-inflammatory effects but also side effects, including reactivation of the arthritis when corticoid therapy is withdrawn. 6 Clinically, this rebound phenomenon is an untoward side effect of corticoid therapy. In a previous paper we reported that rebound of the granulomatous inflammation occurs after withdrawal of corticoid therapy. mined by measuring the thickness of the ankle joint as well. The antibody titre increased rapidly after day 5 and reached a plateau on day 11 after primary immunisation, and then the maximum value was maintained for two weeks (Fig. 1) . The hind paw swelling increased about four days later than the anti-type II collagen antibodies, reached a maximum value on day 17, and then declined gradually. On day 11 there was positive correlation between hind paw diameter and anti-type II collagen antibody titre in the serum (r=0.82, p<001). The results, therefore, suggest that a significant rise of the anti-type II collagen antibodies in plasma may be essential to the incidence of arthritis.
Antibodies to type II collagen in plasma were significantly reduced on day 3 after daily oral administration of dexamethasone (0-3 mg/kg/day) (the antibody titres (-log2) before and after the steroid treatment were 11.84 (0-25) and 10-92 (0-34) (the mean (SEM), n=7) respectively), but no change was found after treatment with indomethacin (3.0 mg/kg/day) (data not shown). Similarly, non-steroidal anti-inflammatory drugs, benoxaprofen (10 mg/kg/day), tiflamizole (0-3 mg/kg on first day, 0-04 mg/kg/day from second to fourth day), and piroxicam (5-0 mg/kg/day) did not reduce anti-type II collagen antibodies on day 3 or day 4 after daily oral administration of these drugs (data not shown).
EFFECT OF ANTI-INFLAMMATORY DRUGS ON THE HIND PAW OEDEMA
Typical inhibitory patterns of dexamethasone and indomethacin on the type II collagen induced arthritis in rats are shown in Fig. 2 , and the inhibitory effects of steroidal and non-steroidal anti-inflammatory drugs on the experimental arthritis are summarised in Table 1 . After withdrawal of dexamethasone a marked rebound phenomenon occurred, i.e., the hind paw oedema rapidly increased and slightly exceeded the control level, and a weak rebound phenomenon was found after withdrawal of indomethacin (Fig. 2a) . Similarly, steroidal anti-inflammatory drugs such as prednisolone (10 mg/kg/day) and hydrocortisone (30 mg//kg/ day) suppressed the hind paw oedema but were followed by a rebound phenomenon after their withdrawal (Table 1 ; data not shown in Fig. 2 ). On the other hand, tiflamizole and the new nonsteroidal anti-inflammatory drugs, piroxicam and benoxaprofen, which are known as cyclo-oxygenase inhibitors,8 9 significantly suppressed the hind paw oedema without rebound phenomenon after withdrawal of the drugs (Fig. 2b and Table 1 ). If the hind paw diameter of the control group remains constant during the course of experiments (from day 16 to day 33) and the suppressed hind paw diameter rebounds to the original value after withdrawal of a drug, the ratio (B) the area after withdrawal of a drug to (A) the area during the drug treatment is close to 0-89 in the rebound group (8 (days after withdrawal of drug)/9 (days of drug treatment)). In the present experiments, however, the paw diameter of the control group gradually declined from day 16 to day 33, suggesting that a minimum value of the ratio in the rebound group is less than 0-89, but probably higher than 0-80 in the present experimental conditions. Table 1 indicates that the area ratio (B)/(A) is close to 0-5 (usually less than 0.8) in the non-rebound group, whereas the ratio is usually higher than 0-8 in the rebound group, which includes the steroidal anti-inflammatory drugs. As shown in Table 1 steroidal anti-inflammatory drugs cause the rebound phenomenon, which may occur owing to a reduction of the secretion of endogenous glucocorticoids as a result of administration of exogenous steroids. On the other hand, the area ratio, (B)/(A), is lower than 0-8 in the groups phenomenon may not occur. In fact, on day 8 after withdrawal of piroxicam (5.0 mg/kg) its serum concentration was 1.1 ,tg/ml, which was approximately five times as high as IC50 (cyclo-oxygenase inhibition). Similarly, serum concentrations of benoxaprofen and tiflamizole were higher than their IC50 (data not shown). This long plasma half life of the drugs may account for the fact that rebound phenomenon does not occur after withdrawal of piroxicam, benoxaprofen, and tiflamizole. Dose-response curves are shown in Fig. 3 based on the area under the time-course curve during drug treatment ( Table 1 ). The relative potencies of the anti-inflammatory effect of the drugs on the type II collagen induced arthritis in rats were dexamethasone>piroxicam, tiflamizole>indomethacin> benoxaprofen (Fig. 3) . It has been reported that there are some similarities between type II collagen induced arthritis in rats and rheumatoid arthritis.'5 Type II collagen induced arthritis in rats, therefore, may be a relevant animal model for detection of antiarthritic agents and for the investigation of rebound phenomenon after withdrawal of antirheumatic drugs.
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